TITLE

Patent Challenges

AUTHOR(S)
J. W.
PUB. DATE
June 2007
SOURCE
Pharmaceutical Executive;Jun2007, Vol. 27 Issue 6, p24
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports that Thailand Government and other third-world nations are challenging patents on critical therapies, a tactic that is stepping up into a serious international confrontation over intellectual property protection. Thailand has been trying to override drug patents on AIDS therapies and other lifesaving drugs. It has issued compulsory licenses to make or buy generic equivalents of some drug companies.
ACCESSION #
25347220

 

Related Articles

  • Generic Pharmaceuticals: IP's Fiercest Litigation Arena. Andersen, Steven // Corporate Legal Times;Nov2003, Vol. 13 Issue 144, p28 

    Focuses on the complications in the generic drug application for patent rights by pharmaceutical companies in the U.S. Employment of strategy to extend the patent life of their products; Impact of the emergence of generic drugs on the pharmaceutical companies; Overview of the process of the...

  • IP vs affordable medicines: the battle heats up.  // PharmacoEconomics & Outcomes News;Mar2014, Vol. 697 Issue 1, p2 

    The article reports on the conflict between India and pharmaceutical companies over intellectual property (IP) law reforms and patent protection in 2014. Topics discussed include the country's use of legal mechanisms to overturn patents, the shift in pharmaceutical companies' attention towards...

  • Senators Mistaken. QUINN, GENE // Inventors' Digest;Jul2015, Vol. 31 Issue 7, p32 

    The article discusses why the U.S.' PATENT Act that was approved in June 2015 by the U.S. Senate Judiciary Committee will not upset the balance reached in Hatch-Waxman legislation which has long ceased to ensure the entry generic drugs into the market. Topics include why intellectual property...

  • Drug firms raided at dawn.  // TCE: The Chemical Engineer;Feb2008, Issue 800, p5 

    The article reports on the raids by the European Competition Commission on GlaxoSmithKline, Pfizer, AstraZeneca and Sanofi-Aventis as part of an investigation into the pharmaceutical industries' use of patents. They are investigating whether these companies have abused patent rights to delay the...

  • India Looks to Ethical Drugs. Scott, Alex // Chemical Week;6/15/2005, Vol. 167 Issue 20, p27 

    Reports on the efforts of pharmaceutical manufacturing sector in India to comply with patent laws for the protection of intellectual property. Approach used by Indian custom pharmaceutical manufacturers in the production of generic drugs; Comparison between the development costs of a drug in...

  • Patent expirations spell big changes for generic industry. Cassell, Dana K. // Drug Topics;8/6/2001 Supplement, Vol. 145 Issue 15, p9 

    Focuses on the increase of patent expirations among pharmaceutical industries in the United States. List of top eight drugs going off patent before December 2005; Delay of patent expiration due to court trials; Plan of an educational campaign on safety and efficacy of generic drugs.

  • Patients' groups voice patent fears.  // Telegraph (Calcutta, India);1/24/2015, p6 

    The article reports on the concerns of the health and patients' rights groups on the possible impact of the bilateral talks on the intellectual property rights that will allow drug companies to sell affordable generic medicines.

  • Under Review.  // Pharmaceutical Executive;May2002, Vol. 22 Issue 5, p142 

    Highlights several issues critical to the pharmaceutical industry that need to be addressed. Need to balance companies' intellectual property rights with patients' right to access lower-priced generics; Pharmacovigilance and fast-track registration; Biotechnology issues.

  • Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health? Oliveira, Maria Auxiliadora; Bermudez, Jorge Antonio Zepeda; Chaves, Gabriela Costa; Velásquez, Germán // Bulletin of the World Health Organization;Nov2004, Vol. 82 Issue 11, p815 

    Objective The World Trade Organization's Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement establishes minimum standards for intellectual property rights, including patent protection for pharmaceuticals; therefore, it may make it difficult for developing countries to gain...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics